Seattle and the Greater Puget Sound Ranks Ninth in GEN’s Top 10 US Biopharma Clusters 2025

Seattle and Greater Puget Sound region landed a spot among the Top 10 U.S. biopharma clusters in 2025, maintaining its reputation as a vital center for life sciences. The region continues to perform strongly across key metrics: it ranks in the top ten for venture capital funding, NIH funding, patent activity, lab space and employment, underscoring the deep innovation ecosystem supported by institutions and industry players. This recognition highlights the Puget Sound as a top life sciences hub in the U.S. for the third consecutive year, reinforcing its leadership in drug discovery, clinical research and biopharma innovation.